BILL PT 2
PATIENT SERIES - PART TWO
Papillary Renal Cell Carcinoma Type 1
Winter 2020. Since our Spring 2018 research collaboration with Bill Paseman he has become a valuable advisor to our program and visible advocate in the patient genomic data sharing community. We're happy to announce new data is available for Bill's case and invite you to join us at the Molecular Medicine Tri-Conference Hackathon - led by our long time collaborators and advisors Ryan Leung and Ben Busby.
Papillary renal-cell carcinoma, accounts for between 15 to 20% of all kidney cancers. It occurs in the cells lining the small tubules in the kidney that filter waste from the blood and make urine. Little is known about the genetic basis of sporadic papillary renal-cell carcinoma, and no effective forms of therapy for advanced disease exist.
Research analysis will be presented to Bill and his medical team. Leading analysis will be featured in our case results.
Papillary Renal Cell Carcinoma Type 1 research for Bill, March 3rd and 4th at the Moscone Center in San Francisco.
Our work is made possible with support from:
